Substituted indazole-O-glucosides
Details for Australian Patent Application No. 2004261264 (hide)
International Classifications
Event Publications
5 October 2006 Section 223 Application Received
JANSSEN PHARMACEUTICA N.V.; TANABE SEIYAKU CO., LTD An application to extend the time from 01 Mar 2006 to 01 Aug 2006 in which to enter the National Phase has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
7 December 2006 Section 223 Application Allowed
Janssen Pharmaceutica N.V.; Tanabe Seiyaku Co., Ltd The time in which to enter the National Phase has been extended to 01 Aug 2006. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
14 December 2006 PCT application entered the National Phase
PCT publication WO2005/011592 Priority application(s): WO2005/011592
24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004261267-Pyridyl derivatives and their use as therapeutic agents
2004261260-Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser